Marqeta (MQ) is back in focus after setting expectations for its third quarter. Management is guiding to revenue growth of 6% to 8% and adjusted EBITDA expansion of 20% to 25%.
Recent interest around Marqeta has come alongside a 30-day share price return of 7.26% and a 90-day gain of 9.89%. However, the year-to-date share price return is still down 6.03%, and the 1-year total shareholder return has declined 13.83%, so recent momentum is improving off a weaker longer-term base.
Compare Marqeta's setup with a curated group of payment and fintech players by scanning the list of solid balance sheet and fundamentals (25 results) that combines balance sheet strength with underlying business resilience.
Bulls point to Marqeta's guidance and earnings momentum, while bears highlight the long slide in shareholder returns. Which side does the current valuation actually support next?
Most Popular Narrative: 16% Undervalued
Marqeta's most followed narrative pegs fair value at $20.74, above the last close at $17.44. This creates a valuation gap that hinges on whether its product and geographic expansion can translate into durable earnings power.
The completed TransactPay acquisition gives Marqeta full program management and EMI capabilities in Europe, enabling entry into larger enterprise opportunities, uniformity of service across North America and Europe, and easier multi-market expansion for clients. This unlocks new revenue streams, increases take rates, and improves earnings scalability.
See why 13 investors see Marqeta as 16% undervalued .
At the center of this view is a discounted cash flow style framework that uses a 7.18% discount rate along with analyst assumptions for revenue growth, margin expansion and a future P/E multiple to arrive at that $20.74 fair value estimate. The same narrative links this outcome to expectations that earnings can compound meaningfully over time and that Marqeta can support a higher valuation multiple than the broader US diversified financials group if those forecasts play out.
Sense check that story against your own expectations for Marqeta's client concentration, competitive pressures in card issuing, and the pace of adoption for newer offerings like AI driven fraud tools before deciding whether that 16% gap between fair value and the current $17.44 price feels realistic for you.
Result: Fair Value of $20.74 (UNDERVALUED)
Still, the narrative cracks quickly if a heavyweight client like Block scales back volumes, or if rising competition in card issuing squeezes Marqeta's take rate assumptions.
Find out about the key risks to this Marqeta narrative .
Another View: Marqeta Looks Expensive On Sales
On a simple P/S check, Marqeta screens as pricey. The stock trades around 2.7x sales, compared with a 2.1x average for the US diversified financials group and a 0.9x peer average, while the fair ratio sits at 2.1x. That gap suggests limited room for error if growth or margins come in softer than hoped.
If you lean on this kind of comparison, you are effectively asking whether Marqeta has enough earnings power ahead to justify a premium to both peers and its own fair ratio, or whether the market could drift back toward that 2.1x anchor over time.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Conflicted on whether recent optimism around Marqeta outweighs the earlier share price drag. Move quickly, review the underlying data, and pressure test the 2 key rewards .
Looking for more investment ideas beyond Marqeta?
If Marqeta has sharpened your focus on quality, broaden your watchlist with a few focused sets of opportunities that match different portfolio goals.
-
Target potential bargains in strong operators and stress test your valuation views against the 27 high quality undervalued stocks .
-
Prioritise resilience and capital preservation by scanning the 31 resilient stocks with low risk scores before market conditions shift again.
-
Hunt for future leaders early by tracking the 20 high quality undiscovered gems while they are still off most investors' radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MQ .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
